Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | FABP7 | O15540 | 2/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1567175 | 0.80 | HTR2A (0.54) | HTR2ACA1CA2FABP7FABP5 | |
| SCHEMBL4910851 | 0.79 | HTR2A (0.58) | HTR2ACA1CA2GPR3HDAC3 | |
| SCHEMBL7576966 | 0.78 | HTR2A (0.64) | HTR2ACA1CA2GPR3HDAC3 | |
| SCHEMBL5353138 | 0.78 | HTR2A (0.64) | HTR2ACA1CA2GPR3KMT2A | |
| SCHEMBL7574105 | 0.76 | HTR2A (0.61) | HTR2ACA1CA2GPR3KMT2A | |
| SCHEMBL17022715 | 0.76 | HTR2A (0.61) | HTR2ACA1CA2GPR3KMT2A | |
| SCHEMBL2286468 | 0.74 | HTR2A (0.58) | HTR2ACA1CA2FABP7FABP5 | |
| SCHEMBL499897 | 0.74 | HTR2A (0.58) | HTR2ACA1CA2GPR3HDAC3 | |
| SCHEMBL22664654 | 0.74 | HTR2A (0.58) | HTR2ACA1CA2GPR3TSHR | |
| SCHEMBL633764 | 0.74 | HTR2A (0.58) | HTR2ACA1CA2GPR3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924154-A | Preparation method of piperidine-2-formate compound | 浙江九洲药业股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117285598-B | Nano peptide F3FT for resisting intracellular gram positive bacteria infection, and preparation method and application thereof | 东北农业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-115368363-B | Chiral or racemized pyrimidodiazepinone compound and preparation method and application thereof | 中山大学 | 2024-02-20 | — | — | CN | claimed |
| CN-116867795-A | Novel method for producing antibody-immunostimulant conjugate | 第一三共株式会社 | 2023-10-10 | — | — | CN | claimed |
| CN-116685576-A | Cysteine protease inhibitors and methods of use thereof | 美商帕迪斯生物科学公司 | 2023-09-01 | — | — | CN | claimed |
| WO-2023136470-A1 | PNA MONOMER AND PNA OLIGOMER INCLUDING SAME | 주식회사 시선바이오머티리얼스 | 2023-07-20 | — | — | WO | claimed |
| US-20230212152-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | Pardes Biosciences, Inc. | 2023-07-06 | — | — | US | claimed |
| CN-110272544-B | Oligomer, composition, article, method for preparing article, and display device | 三星电子株式会社 | 2023-07-04 | — | — | CN | claimed |
| WO-2023104021-A1 | METABOLIC CHECKPOINT-BASED HUMAN SERUM ALBUMIN NANO-DRUG, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 深圳先进技术研究院 | 2023-06-15 | — | — | WO | claimed |
| CN-114163354-B | Preparation method of N-fluorenylmethoxycarbonyl-N-trityl-L-asparagine | 常州吉恩药业有限公司 | 2023-05-05 | — | — | CN | claimed |
| EP-0245662-B1 | P-HYDROXYPHENYLSULFONIUM SALTS AND THEIR USE IN THE PREPARATION OF ESTERS AND AMIDES | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1991-08-07 | — | — | EP | claimed |
| US-5021197-A | Reacting a p-dialkylsulfoniophenol with a carbonyl halogenide in the presence of a secondary amine | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-06-04 | — | — | US | claimed |
| US-4990644-A | Water solubility | SANSHIN KAGAKU KOGYO CO. LTD. (JP) | 1991-02-05 | — | — | US | claimed |
| EP-0406567-A2 | Process for the production of sulfonium compounds and novel methylthiophenol derivatives | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1991-01-09 | — | — | EP | claimed |
| EP-0393893-A1 | Sulfonium compound and polymerisation initator comprising the sulfonium compound as the main ingredient | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1990-10-24 | — | — | EP | claimed |
| EP-0375047-A2 | New process for the synthesis of N alpha-fluorenylmethoxycarbonyl-Ng-trityl-arginine | SCLAVO S.p.A. (IT) | 1990-06-27 | — | — | EP | claimed |
| EP-0346756-A1 | Process for production of sulfonium compounds | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1989-12-20 | — | — | EP | claimed |
| EP-0331988-A1 | Sulfonium compounds, as well as process for producing active esters and amides used for the production of amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1989-09-13 | — | — | EP | claimed |
| US-4857656-A | Active esters used for production of esters or amides and process for producing esters or amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1989-08-15 | — | — | US | claimed |
| EP-0245662-A1 | p-Hydroxyphenylsulfonium salts and their use in the preparation of esters and amides | SANSHIN KAGAKU KOGYO CO., LTD. (JP) | 1987-11-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212152-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF | CTRL, CTSL, CTSV | HTR2A 3835/4885CA1 545/4885CA2 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.